| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 622 |
| 1 | PREDNISONE | 398 |
| 2 | INFLIXIMAB | 299 |
| 3 | METHOTREXATE SODIUM | 207 |
| 4 | VEDOLIZUMAB | 206 |
| 5 | METHYLPREDNISOLONE | 197 |
| 6 | METHOTREXATE | 189 |
| 7 | RITUXIMAB | 188 |
| 8 | METRONIDAZOLE | 173 |
| 9 | ACETAMINOPHEN | 170 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN HUMAN AND FIBRINOGEN | 10 | 0.0299 |
| 1 | SEROTONIN | 4 | 0.0151 |
| 2 | PHENAZOPYRIDINE HYDROCHLORIDE | 3 | 0.0092 |
| 3 | ACITRETIN | 44 | 0.0091 |
| 4 | BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI | 2 | 0.0068 |
| 5 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 2 | 0.0053 |
| 6 | APOMORPHINE HYDROCHLORIDE | 4 | 0.0050 |
| 7 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 2 | 0.0047 |
| 8 | ACETYLCYSTEINE | 43 | 0.0046 |
| 9 | MITOTANE | 7 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 848 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 538 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 385 |
| 3 | Interleukin-23 Antagonist [EPC] | 257 |
| 4 | Integrin Receptor Antagonist [EPC] | 234 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 223 |
| 6 | Platinum-based Drug [EPC] | 214 |
| 7 | Benzodiazepine [EPC] | 193 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 189 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 181 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 10 | 0.0299 |
| 1 | GLP-2 Analog [EPC] | 44 | 0.0033 |
| 2 | Vitamin K [EPC] | 13 | 0.0031 |
| 3 | Nitroimidazole Antimicrobial [EPC] | 174 | 0.0027 |
| 4 | CD123 Interaction [EPC] | 1 | 0.0019 |
| 5 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 6 | Interleukin-2 Receptor Blocking Antibody [EPC] | 21 | 0.0018 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 11 | 0.0018 |
| 8 | Echinocandin Antifungal [EPC] | 14 | 0.0018 |
| 9 | Purine Antimetabolite [EPC] | 167 | 0.0017 |